David Preiss

1971–2026 年に発表

92
論文数
22,809
被引用数
58
h 指数
89
i10 指数

被引用数

David Preiss の年別被引用数1985 年: 被引用 3 件1990 年: 被引用 1 件1991 年: 被引用 2 件1992 年: 被引用 3 件1993 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 2 件1996 年: 被引用 6 件1997 年: 被引用 7 件1998 年: 被引用 1 件1999 年: 被引用 9 件2000 年: 被引用 8 件2001 年: 被引用 12 件2002 年: 被引用 4 件2003 年: 被引用 4 件2004 年: 被引用 5 件2005 年: 被引用 8 件2006 年: 被引用 7 件2007 年: 被引用 12 件2008 年: 被引用 21 件2009 年: 被引用 40 件2010 年: 被引用 78 件2011 年: 被引用 92 件2012 年: 被引用 130 件2013 年: 被引用 132 件2014 年: 被引用 140 件2015 年: 被引用 152 件2016 年: 被引用 217 件2017 年: 被引用 223 件2018 年: 被引用 233 件2019 年: 被引用 752 件2020 年: 被引用 887 件2021 年: 被引用 887 件2022 年: 被引用 781 件2023 年: 被引用 678 件2024 年: 被引用 1,174 件2025 年: 被引用 517 件2026 年: 被引用 51 件1986〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,226 件、この内訳の 18.5%イギリス: 引用元論文 1,218 件、この内訳の 10.1%中国: 引用元論文 848 件、この内訳の 7%イタリア: 引用元論文 635 件、この内訳の 5.3%カナダ: 引用元論文 615 件、この内訳の 5.1%ドイツ: 引用元論文 534 件、この内訳の 4.4%オーストラリア: 引用元論文 463 件、この内訳の 3.8%オランダ: 引用元論文 407 件、この内訳の 3.4%フランス: 引用元論文 346 件、この内訳の 2.9%スペイン: 引用元論文 309 件、この内訳の 2.6%スウェーデン: 引用元論文 306 件、この内訳の 2.5%日本: 引用元論文 279 件、この内訳の 2.3%
0%18.5%その他 32.1%

分野

  • Medicine78.5%
  • Biochemistry, Genetics and Molecular Biology10.6%
  • Mathematics1.7%
  • Computer Science1.5%
  • Psychology1.3%
  • Immunology and Microbiology1.2%
  • その他5.2%

トピック

  • Diabetes Treatment and Management8.5%
  • Lipoproteins and Cardiovascular Health7.7%
  • Diabetes, Cardiovascular Risks, and Lipoproteins5.1%
  • Liver Disease Diagnosis and Treatment2.5%
  • Metabolism, Diabetes, and Cancer2.5%
  • Pancreatic function and diabetes2.3%
  • その他71.4%

共著者

全論文

検索で開く
  1. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brendon L. Neuen, Milton Packer, Vlado Perkovic, Marc S. Sabatine, Scott D. Solomon, Muthiah Vaduganathan, Christoph Wanner, David C. Wheeler, Stephen D. Wiviott, Faı̈ez Zannad - The Lancet 2022 被引用: 974

  2. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

    著者: , , , , , , , , - The Lancet Diabetes & Endocrinology 2019 被引用: 1,614

  3. Interpretation of the evidence for the efficacy and safety of statin therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2016 被引用: 1,844

  4. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kyoichi Mizuno, Kausik K. Ray, Ian Ford - The Lancet 2010 被引用: 2,447

  5. GDF15 mediates the effects of metformin on body weight and energy balance

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David B. Savage, Bernard B. Allan, Stephen O’Rahilly - Nature 2019 被引用: 570

  6. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

    著者: , , , , , , , , , , , , , , - Arteriosclerosis Thrombosis and Vascular Biology 2019 被引用: 710

  7. Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Т. В. Балахонова, Eiichi Sato, Mayuko Amaha, Tsukasa Nakamura, Kostas Kapellas, Lisa Jamieson, Michael R. Skilton, James A. Blumenthal, Alan L. Hinderliter, Andrew Sherwood, Patrick J. Smith, Michiel A. van Agtmael, Peter Reiss, Marit G. A. van Vonderen, Stefan Kiechl, Gerhard Klingenschmid, Matthias Sitzer, Coen D.A. Stehouwer, Heiko Uthoff, Zhi-Yong Zou, Ana Rosa Cunha, Mário Fritsch Neves, Miles D. Witham, Hyun Woong Park, Moo‐Sik Lee, Jang‐Ho Bae, Enrique Bernal, Kristian Wachtell, Sverre E. Kjeldsen, Michael Hecht Olsen, David Preiss, Naveed Sattar, Edith D. Beishuizen, Menno V. Huisman, Mark A. Espeland, Caroline Schmidt, Stefan Agewall, Ercan Ok, Gülay Aşçı, Eric de Groot, Muriël P.C. Grooteman, Peter J. Blankestijn, Michiel L. Bots, Michael Sweeting, Simon G. Thompson, Matthias Lorenz, For the PROG-IMT and the Proof-ATHERO Study Groups - Circulation 2020 被引用: 443

  8. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heather Halls, Charlie Harper, C. Hawkins, William G. Herrington, G. A. Hitman, Hallvard Holdaas, Lisa Holland, Alan G. Jardine, J. Wouter Jukema, John J.P. Kastelein, Sharon Kean, Anthony Keech, Adrienne Kirby, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Wolfgang Köenig, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Eva Lonn, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Ian C. Marschner, Borislava Mihaylova, Lemuel A. Moyé, Sabina A. Murphy, Haruo Nakamura, Andrew Neil, Connie B. Newman, Rachel O’Connell, Chris J. Packard, Sarah Parish, Terje Pedersen, Richard Peto, Marc A. Pfeffer, Neil Poulter, David Preiss, Christina Reith, Paul M. Ridker, Michele Robertson, Frank M. Sacks, Naveed Sattar, Roland E. Schmieder, Patrick W. Serruys, Peter Sever, John Shaw, Charles L. Shear, John Simes, Peter Sleight, Enti Spata, Luigi Tavazzi, Jonathan A. Tobert, Gianni Tognoni, Andrew Tonkin, Stella Trompet, George Varigos, Christoph Wanner, Hans Wedel, Harvey D. White, John Wikstrand, Lars Wilhelmsen, Kate Wilson, Robin Young, Salim Yusuf, Faı̈ez Zannad - The Lancet 2019 被引用: 791

  9. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Clearfield, Stuart M. Cobbe, Helen M. Colhoun, Björn Dahlöf, Barry R. Davis, James A. de Lemos, John R. Downs, Paul N. Durrington, Bengt Fellström, Ian Ford, Maria Grazia Franzosi, John A. Fuller, Curt D. Furberg, Robert J. Glynn, David Gordon, Antonio M. Gotto, Richard H. Grimm, Ajay Gupta, C. Hawkins, G. A. Hitman, Hallvard Holdaas, Alan G. Jardine, J. Wouter Jukema, John J.P. Kastelein, Sharon Kean, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Wolfgang Köenig, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Roberto Latini, Eva Lonn, Donata Lucci, Jean MacFadyen, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Ian C. Marschner, Lemuel A. Moyé, Sabina A. Murphy, Andrew Neil, Enrico Nicolis, Chris J. Packard, Sarah Parish, Terje R. Pedersen, Richard Peto, Marc A. Pfeffer, Neil R Poulter, Sara Pressel, Jeffrey L. Probstfield, Mahboob Rahman, Paul M. Ridker, Michele Robertson, Frank M. Sacks, Naveed Sattar, Roland E. Schmieder, Patrick W. Serruys, Peter Sever, John Shaw, James Shepherd, Lara M. Simpson, Peter Sleight, Luigi Tavazzi, Gianni Tognoni, Andrew Tonkin, Stella Trompet ほか 28 名 - The Lancet 2022 被引用: 246

  10. Cardiac Troponin T and Troponin I in the General Population

    著者: , , , , , , , , , , , , , , - Circulation 2019 被引用: 327

  11. Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katherine R. Tuttle, Dominik Steubl, Daisy Massey, Martin Landray, Colin Baigent, Richard Haynes, WG Herrington, S Abat, Riaz Rahman, Rizna Abdul Cader, MI Abdul Hafidz, MZ Abdul Wahab, NK Abdullah, Talal Abdulsamad, Masanori Abe, Nader G. Abraham, Sarah Acheampong, P Achiri, JA Acosta, A. Q. Adeleke, Vicki Adell, R Adewuyi-Dalton, Nihad Adnan, A Africano, Mohsen Agharazii, Frank G. Aguilar, A Aguilera, Movahedian Ahmad, MK Ahmad, NA Ahmad, NH Ahmad, NI Ahmad, Norazinizah Ahmad Miswan, H Ahmad Rosdi, Iffat Ahmed, Sofia B. Ahmed, Sofia B. Ahmed, Joan Aiello, A. Aitken, R AitSadi, Sendogan Aker, S Akimoto, A Akinfolarin, S. Akram, Federico Alberici, Christian Albert, Leslie N. Aldrich, M Alegata, Lee Alexander, S Alfaress, Mohammad Alhadj Ali, Ahmed Issam Ali, Ahmed Issam Ali, Radica Z. Alicic, A Aliu, Ricardo López Almaraz, Rashid Almasarwah, Jussara Carnevale de Almeida, Alessia Aloisi, Laith Al‐Rabadi, Mark Dominik Alscher, Pedro Álvarez, Bader Al-Zeer, Mora Amat, Christopher S. Ambrose, Hany Ammar, Yu An, L Andriaccio, Kwame Ansu, A Apostolidi ほか 1,572 名 - The Lancet Diabetes & Endocrinology 2023 被引用: 108

  12. Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy

    著者: - JAMA 2011 被引用: 1,385

  13. Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stella Trompet, Harvey D. White, Salim Yusuf, Jane Armitage, Anthony Keech, John Simes, Rory Collins, Colin Baigent, Elizabeth H Barnes, Jordan Fulcher, William G. Herrington, Adrienne Kirby, Rachel O’Connell, Pierre Amarenco, Hiroyuki Arashi, Philip J. Barter, D. J. Betteridge, Michael A. Blazing, Gerard J Blauw, Jackie Bosch, Louise Bowman, Eugene Braunwald, Richard Bulbulia, Robert Byington, Michael Clearfield, Stuart M. Cobbe, Björn Dahlöf, Barry R. Davis, James A. de Lemos, John R. Downs, Bengt Fellström, Marcus Flather, Ian Ford, Maria Grazia Franzosi, John A. Fuller, Curt D. Furberg, Robert J. Glynn, Uri Goldbourt, David Gordon, Antonio M. Gotto, Richard Grimm, A Gupta, C. Hawkins, Richard Haynes, Hallvard Holdaas, Jemma C. Hopewell, Alan G. Jardine, John J.P. Kastelein, Sharon Kean, Patricia M. Kearney, George D. Kitas, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Roberto Latini, Eva Lonn, Donata Lucci, Jean MacFadyen, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Lemuel A. Moyé, Sabina A. Murphy, Andrew Neil, Enrico Nicolis ほか 32 名 - The Lancet Diabetes & Endocrinology 2024 被引用: 137

  14. Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance

    著者: , , , , , , , , , , , , , , , , , , - JAMA 2016 被引用: 511

  15. Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dominik Steubl, Michaela Petrini, Siegfried Seidi, Martin Landray, Colin Baigent, WG Herrington, Sharirose Abat, Riaz Rahman, Rizna Abdul Cader, MI Abdul Hafidz, MZ Abdul Wahab, NK Abdullah, Talal Abdulsamad, Masami Abe, Ned Abraham, Sarah Acheampong, P Achiri, JA Acosta, A A Adeleke, Vicki Adell, R Adewuyi-Dalton, Nihad Adnan, A Africano, Mohsen Agharazii, Frank G. Aguilar, A Aguilera, M Ahmad, MK Ahmad, NA Ahmad, NH Ahmad, NI Ahmad, Norazinizah Ahmad Miswan, H Ahmad Rosdi, Iffat Ahmed, Sofia B. Ahmed, Sofia B. Ahmed, Joan Aiello, Alastair Aitken, R AitSadi, Sendogan Aker, S Akimoto, Akinwande A. Akinfolarin, S. Akram, Federico Alberici, Christian Albert, Luke Aldrich, M Alegata, Lacy M. Alexander, S Alfaress, Mohammad Alhadj Ali, A Ali, A Ali, Radica Z. Alicic, Arta Aliu, Ricardo López Almaraz, Rashid Almasarwah, Jussara Carnevale de Almeida, Alessia Aloisi, Laith Al‐Rabadi, Mark Dominik Alscher, Pedro Álvarez, Bader Al-Zeer, M. Ochoa de Olza Amat, Christopher S. Ambrose, Hany Ammar, Yu An, L Andriaccio, K Ansu, A Apostolidi, N. Arai ほか 1,571 名 - The Lancet Diabetes & Endocrinology 2023 被引用: 90

  16. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nita G. Forouhi, N. Charlotte Onland‐Moret, Yvonne T. van der Schouw, Renate B. Schnabel, Jaroslav A. Hubáček, Růžena Kubínová, Miglė Bacevičienė, Abdonas Tamošiūnas, Andrzej Pająk, Romanvan Topor-Madry, Urszula Stepaniak, Sofia Malyutina, Damiano Baldassarre, Bengt Sennblad, Elena Tremoli, Ulf dé Fairé, Fabrizio Veglia, Ian Ford, J. Wouter Jukema, Rudi G. J. Westendorp, Gert J. de Borst, Pim A. de Jong, Ale Algra, Wilko Spiering, Anke H. Maitland‐van der Zee, Olaf H. Klungel, Anthonius de Boer, Pieter A. Doevendans, Charles B. Eaton, Jennifer G. Robinson, David Duggan, John Kjekshus, John R. Downs, Antonio M. Gotto, Anthony Keech, Roberto Marchioli, Gianni Tognoni, Peter S. Sever, Neil R Poulter, David D. Waters, Terje R. Pedersen, Pierre Amarenco, Haruo Nakamura, John J.V. McMurray, James Lewsey, Daniel I. Chasman, Paul M. Ridker, Aldo P. Maggioni, Luigi Tavazzi, Kausik K. Ray, Sreenivasa Rao Kondapally Seshasai, JoAnn E. Manson, Jackie F. Price, Peter H. Whincup, Richard Morris, Debbie A. Lawlor, George Davey Smith, Yoav Ben‐Shlomo, Pamela J. Schreiner, Myriam Fornage, David S. Siscovick, Mary Cushman, Meena Kumari, Nick J Wareham, W. M. Monique Verschuren, Susan Redline, Sanjay R. Patel, John C. Whittaker, Anders Hamsten, Joseph A. Delaney ほか 33 名 - The Lancet 2014 被引用: 710

  17. Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sagar N. Doshi, Moira Dryburgh, Michael Eddleston, Jim Finlayson, Ahmet Fuat, Jacqueline Furnace, JW Kerr Grieve, Greg Guthrie, Sharon Ham, Emma Isaard, Claudine G. Jennings, Richard J. Johnson, Claire Kerr, Sohail Khan, Kailash Krishnan, Susan Long, A. S. Mackintosh, Mary Joan MacLeod, Terry McCormack, Paul McEleny, Monique Morar, Adnan Nadir, David E. Newby, Colin J. Petrie, David Preiss, Stuart H. Ralston, Marc Randall, Helen Routledge, Saad Shakir, Raj Kumar Sharma, Bridget Shepherd, Don Sims, Gordon Snedden, Jasper Trevelyan, Christopher J. Weir, Robin A.P. Weir, Kirsty Wetherall, Robbie S. Wilson, Adam Wilson, Kris Zutis - The Lancet 2022 被引用: 157

  18. Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes

    著者: , , , , , , , , , - JAMA Cardiology 2016 被引用: 318

  19. Reverse Causality in Cardiovascular Epidemiological Research

    著者: , - Circulation 2017 被引用: 216

  20. Non-alcoholic fatty liver disease

    著者: , , - BMJ 2014 被引用: 327

  21. Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2023 被引用: 44

  22. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

    著者: , , , , , , , - The Lancet 2009 被引用: 1,388

  23. Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction

    著者: , , , , , , , , , , , , , , , , , - Circulation Heart Failure 2016 被引用: 352

  24. Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis

    著者: , , , , , , , , , , , , , , , , - BMC Nephrology 2016 被引用: 209